Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carya tomentosa pollen is an allergenic extract derived from the mockernut hickory (also known as white hickory). It is utilized both as a diagnostic tool for skin testing and as a therapeutic agent in allergen immunotherapy (AIT) for patients suffering from allergic rhinitis or other hypersensitivity reactions triggered by hickory tree pollen. The extract works by exposing the patient's immune system to controlled amounts of the allergen, eventually inducing desensitization and reducing clinical symptoms. It is typically administered via subcutaneous injection and may be formulated as a single-species extract or as part of a broader hickory or tree pollen mixture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carya tomentosa pollen.